Cargando…
Response: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes metab J 2019;43;276-86)
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Diabetes Association
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712230/ https://www.ncbi.nlm.nih.gov/pubmed/31441250 http://dx.doi.org/10.4093/dmj.2019.0148 |
| _version_ | 1783446639832203264 |
|---|---|
| author | Oh, Tae Jung Choi, Sung Hee |
| author_facet | Oh, Tae Jung Choi, Sung Hee |
| author_sort | Oh, Tae Jung |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6712230 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Korean Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67122302019-09-04 Response: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes metab J 2019;43;276-86) Oh, Tae Jung Choi, Sung Hee Diabetes Metab J Response Korean Diabetes Association 2019-08 2019-08-20 /pmc/articles/PMC6712230/ /pubmed/31441250 http://dx.doi.org/10.4093/dmj.2019.0148 Text en Copyright © 2019 Korean Diabetes Association http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Response Oh, Tae Jung Choi, Sung Hee Response: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes metab J 2019;43;276-86) |
| title | Response: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes metab J 2019;43;276-86) |
| title_full | Response: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes metab J 2019;43;276-86) |
| title_fullStr | Response: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes metab J 2019;43;276-86) |
| title_full_unstemmed | Response: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes metab J 2019;43;276-86) |
| title_short | Response: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes metab J 2019;43;276-86) |
| title_sort | response: efficacy and safety of voglibose plus metformin in patients with type 2 diabetes mellitus: a randomized controlled trial (diabetes metab j 2019;43;276-86) |
| topic | Response |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712230/ https://www.ncbi.nlm.nih.gov/pubmed/31441250 http://dx.doi.org/10.4093/dmj.2019.0148 |
| work_keys_str_mv | AT ohtaejung responseefficacyandsafetyofvogliboseplusmetformininpatientswithtype2diabetesmellitusarandomizedcontrolledtrialdiabetesmetabj20194327686 AT choisunghee responseefficacyandsafetyofvogliboseplusmetformininpatientswithtype2diabetesmellitusarandomizedcontrolledtrialdiabetesmetabj20194327686 |